8:00 am Registration & Coffee

8:30 am Chair’s Opening Remarks

8:55 am The Progress of the Industry Leaders: Get your questions on the pipelines of the leading allogeneic developers answered

• Chris Bond VP, Cellular Engineering, Kite Pharma
• Lan Cao Senior Director, Head of Product Development & Global Program Leader, Cell Therapy , Takeda
• Blake Aftab VP, Preclinical & Translational Science, Atara Biotherapeutics
• Mark Leonard VP, Process & Product Development Allogene Therapeutics, Mark Leonard

10:00 am Commercially Viable iPSC-Based Therapies – a CDMO View

• Marcos Langtry Head of Allogeneic Cell Therapy Commercial Development , Lonza Pharma & Biotech

10:30 am Speed Networking

11:00 am Morning Refreshments

1:00 pm Lunch & Networking

3:00 pm Afternoon Refreshments & Poster Session

5:00 pm End of Day 1

Evening Drinks Reception